TRDA vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 05, 2026

TRDA

42.6
AI Score
VS
CBIO Wins

CBIO

43.4
AI Score

Investment Advisor Scores

TRDA

43score
Recommendation
HOLD

CBIO

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric TRDA CBIO Winner
Revenue 875,000 1.04M CBIO
Net Income -39.72M -48.12M TRDA
Net Margin -4539.1% -4631.4% TRDA
Operating Income -42.30M -51.09M TRDA
ROE -14.7% -29.5% TRDA
ROA -11.8% -26.3% TRDA
Total Assets 335.52M 182.76M TRDA
Cash 76.44M 171.59M CBIO
Current Ratio 13.90 9.66 TRDA
Free Cash Flow -41.74M -28.56M CBIO

Relative Price Performance (Last 90 Days)

TRDA 1M: -26.3% · 3M: -28.6% CBIO 1M: -22.8% · 3M: -15.6%

Current Technical Phase

TRDA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.7%), weak momentum, RSI 29

RSI (14): 28.6 · Price: $5.38

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.6 · Price: $14.32

Fundamentals Snapshot

Metric TRDA CBIO
Market Cap — —
Forward P/E -1.8 -5.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.5% 0.0%
Gross Margin -28.7% 1.0%
Operating Margin -50.1% -14.3%
EPS -3.54 -0.14
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.